Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP285596.RAKBlb9fvPIZpcX1xO4t_wte7b-MNFolYY-WRCe6PwkPA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285596.RAKBlb9fvPIZpcX1xO4t_wte7b-MNFolYY-WRCe6PwkPA130_assertion type Assertion NP285596.RAKBlb9fvPIZpcX1xO4t_wte7b-MNFolYY-WRCe6PwkPA130_head.
- NP285596.RAKBlb9fvPIZpcX1xO4t_wte7b-MNFolYY-WRCe6PwkPA130_assertion description "[The purpose of this study was therefore to investigate expression of TRAIL, FasL, and its receptor Fas on protein and mRNA levels in breast carcinomas (n=40), fibroadenomas (n=7), and normal breast tissues (n=5).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285596.RAKBlb9fvPIZpcX1xO4t_wte7b-MNFolYY-WRCe6PwkPA130_provenance.
- NP285596.RAKBlb9fvPIZpcX1xO4t_wte7b-MNFolYY-WRCe6PwkPA130_assertion evidence source_evidence_literature NP285596.RAKBlb9fvPIZpcX1xO4t_wte7b-MNFolYY-WRCe6PwkPA130_provenance.
- NP285596.RAKBlb9fvPIZpcX1xO4t_wte7b-MNFolYY-WRCe6PwkPA130_assertion SIO_000772 10817673 NP285596.RAKBlb9fvPIZpcX1xO4t_wte7b-MNFolYY-WRCe6PwkPA130_provenance.
- NP285596.RAKBlb9fvPIZpcX1xO4t_wte7b-MNFolYY-WRCe6PwkPA130_assertion wasDerivedFrom befree-20140225 NP285596.RAKBlb9fvPIZpcX1xO4t_wte7b-MNFolYY-WRCe6PwkPA130_provenance.
- NP285596.RAKBlb9fvPIZpcX1xO4t_wte7b-MNFolYY-WRCe6PwkPA130_assertion wasGeneratedBy ECO_0000203 NP285596.RAKBlb9fvPIZpcX1xO4t_wte7b-MNFolYY-WRCe6PwkPA130_provenance.